Literature DB >> 11856822

The structure of the FERM domain of merlin, the neurofibromatosis type 2 gene product.

Beom Sik Kang1, David R Cooper, Yancho Devedjiev, Urszula Derewenda, Zygmunt S Derewenda.   

Abstract

Neurofibromatosis type 2 is an autosomal dominant disorder characterized by central nervous system tumors. The cause of the disease has been traced to mutations in the gene coding for a protein that is alternately called merlin or schwannomin and is a member of the ERM family (ezrin, radixin and moesin). The ERM proteins link the cytoskeleton to the cell membrane either directly through integral membrane proteins or indirectly through membrane-associated proteins. In this paper, the expression, purification, crystallization and crystal structure of the N-terminal domain of merlin are described. The crystals exhibit the symmetry of space group P2(1)2(1)2(1), with two molecules in the asymmetric unit. The recorded diffraction pattern extends to 1.8A resolution. The structure was solved by the molecular-replacement method and the model was refined to a conventional R value of 19.3% (R(free) = 22.7%). The N-terminal domain of merlin closely resembles those described for the corresponding domains in moesin and radixin and exhibits a cloverleaf architecture with three distinct subdomains. The structure allows a better rationalization of the impact of selected disease-causing mutations on the integrity of the protein.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11856822     DOI: 10.1107/s0907444901021175

Source DB:  PubMed          Journal:  Acta Crystallogr D Biol Crystallogr        ISSN: 0907-4449


  16 in total

1.  Structural basis of adhesion-molecule recognition by ERM proteins revealed by the crystal structure of the radixin-ICAM-2 complex.

Authors:  Keisuke Hamada; Toshiyuki Shimizu; Shigenobu Yonemura; Shoichiro Tsukita; Sachiko Tsukita; Toshio Hakoshima
Journal:  EMBO J       Date:  2003-02-03       Impact factor: 11.598

2.  Unfurling of the band 4.1, ezrin, radixin, moesin (FERM) domain of the merlin tumor suppressor.

Authors:  S D Yogesha; Andrew J Sharff; Marco Giovannini; Gerard Bricogne; Tina Izard
Journal:  Protein Sci       Date:  2011-11-09       Impact factor: 6.725

3.  Fluorescence resonance energy transfer analysis of merlin conformational changes.

Authors:  Robert F Hennigan; Lauren A Foster; Mary F Chaiken; Timmy Mani; Michelle M Gomes; Andrew B Herr; Wallace Ip
Journal:  Mol Cell Biol       Date:  2010-01       Impact factor: 4.272

4.  A deletion causing NF2 exon 9 skipping is associated with familial autosomal dominant intramedullary ependymoma.

Authors:  Ilyess Zemmoura; Patrick Vourc'h; Agathe Paubel; Béatrice Parfait; Joëlle Cohen; Frédéric Bilan; Alain Kitzis; Cécilia Rousselot; Fabrice Parker; Patrick François; Christian R Andres
Journal:  Neuro Oncol       Date:  2013-12-18       Impact factor: 12.300

5.  FERM domain phosphoinositide binding targets merlin to the membrane and is essential for its growth-suppressive function.

Authors:  Timmy Mani; Robert F Hennigan; Lauren A Foster; Deborah G Conrady; Andrew B Herr; Wallace Ip
Journal:  Mol Cell Biol       Date:  2011-03-14       Impact factor: 4.272

Review 6.  Merlin and the ERM proteins--regulators of receptor distribution and signaling at the cell cortex.

Authors:  Andrea I McClatchey; Richard G Fehon
Journal:  Trends Cell Biol       Date:  2009-04-01       Impact factor: 20.808

7.  Molecular conformation of the full-length tumor suppressor NF2/Merlin--a small-angle neutron scattering study.

Authors:  Jahan Ali Khajeh; Jeong Ho Ju; Moussoubaou Atchiba; Marc Allaire; Christopher Stanley; William T Heller; David J E Callaway; Zimei Bu
Journal:  J Mol Biol       Date:  2014-05-29       Impact factor: 5.469

8.  Structural basis of the binding of Merlin FERM domain to the E3 ubiquitin ligase substrate adaptor DCAF1.

Authors:  Youjun Li; Zhiyi Wei; Junyi Zhang; Zhou Yang; Mingjie Zhang
Journal:  J Biol Chem       Date:  2014-04-04       Impact factor: 5.157

9.  Localization to the cortical cytoskeleton is necessary for Nf2/merlin-dependent epidermal growth factor receptor silencing.

Authors:  Banumathi K Cole; Marcello Curto; Annie W Chan; Andrea I McClatchey
Journal:  Mol Cell Biol       Date:  2007-12-17       Impact factor: 4.272

10.  Spatial organization of Hippo signaling at the plasma membrane mediated by the tumor suppressor Merlin/NF2.

Authors:  Feng Yin; Jianzhong Yu; Yonggang Zheng; Qian Chen; Nailing Zhang; Duojia Pan
Journal:  Cell       Date:  2013-09-05       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.